Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.

Weiss, Sheila R

Weiss, Sheila R.

Weiss SR; Exponent, Washington, DC.

JAMA ; 327(20): 2019-2020, 2022 05 24.

Article in English | MEDLINE | ID: covidwho-1888452

Subject(s)

COVID-19 Vaccines; COVID-19; Myocarditis; Vaccines, Synthetic; mRNA Vaccines; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/therapeutic use; Humans; Myocarditis/chemically induced; Myocarditis/epidemiology; Myocarditis/etiology; RNA, Messenger; United States/epidemiology; Vaccination/adverse effects; Vaccination/statistics & numerical data; Vaccines, Synthetic/adverse effects; Vaccines, Synthetic/therapeutic use; mRNA Vaccines/adverse effects; mRNA Vaccines/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Synthetic / COVID-19 Vaccines / COVID-19 / MRNA Vaccines / Myocarditis Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google